市場調査レポート

商品コード

1383107

人工涙液の世界市場の予測（～2030年）

Artificial Tears Forecast till 2030

出版日: 2023年11月10日
発行: Market Research Future
ページ情報: 英文 128 Pages
納期: 即納可能

価格

PDF & Excel (Single User License)

USD 4,950 710,671円

レポートPDF、Excelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Multi User License)

USD 5,950 854,241円

レポートPDF、Excelを同一企業内の最大15名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Enterprise License)

USD 7,250 1,040,882円

レポートPDF、Excelを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDF、Excelの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の人工涙液市場は、ドライアイや目の炎症の流行、無添加の商品への志向の高まりにより、成長が促進されています。

地域の考察

北米市場は、ドライアイの普及、市場参入企業のプレゼンスなどにより、最大の市場規模を占めました。米国ではドライアイが非常に広く蔓延しており、人口の大部分、特に50歳以上に影響を及ぼしています。

欧州市場は、眼科疾患の流行、最先端の点眼薬の利用の拡大、急速な人口増加により、第2位の市場となっています。

アジア太平洋市場は調査期間に高速で成長する見込みです。中国市場が最大の市場規模を持ち、インド市場がアジア太平洋でもっとも急速に成長します。

当レポートでは、世界の人工涙液市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

概要
北米
- 米国
- カナダ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他の欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋
その他の地域
- 中東
- アフリカ
- ラテンアメリカ

第11章競合情勢

主な発展と成長戦略
- 製品の発売
- 提携
- 合意
- 買収
- パートナーシップ
主要企業の財務マトリクス
- 売上（2022年）
- 研究開発（2022年）

第12章企業プロファイル

JOHNSON AND JOHNSON VISION CARE
ALLERGAN PLC
ALCON PLC
BAUSCH & LOMB INCORPORATED
SANTEN, INC.
URSAPHARM ARZNEIMITTEL GMBH
ROHTO PHARMACEUTICAL CO., LTD.
SIMILASAN CORPORATION
OCUSOFT
NICOX

第13章付録

図表

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 4 GLOBAL ARTIFICIAL TEARS MARKET, FOR POLYETHYLENE GLYCOL, BY REGION, 2019-2030 (USD BILLION)
TABLE 5 GLOBAL ARTIFICIAL TEARS MARKET, FOR PROPYLENE GLYCOL, BY REGION, 2019-2030 (USD BILLION)
TABLE 6 GLOBAL ARTIFICIAL TEARS MARKET, FOR CELLULOSE, BY REGION, 2019-2030 (USD BILLION)
TABLE 7 GLOBAL ARTIFICIAL TEARS MARKET, FOR GLYCERIN, BY REGION, 2019-2030 (USD BILLION)
TABLE 8 GLOBAL ARTIFICIAL TEARS MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)
TABLE 9 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 10 GLOBAL ARTIFICIAL TEARS MARKET, FOR EYE DROPS, BY REGION, 2019-2030 (USD BILLION)
TABLE 11 GLOBAL ARTIFICIAL TEARS MARKET, FOR OINTMENTS, BY REGION, 2019-2030 (USD BILLION)
TABLE 12 GLOBAL ARTIFICIAL TEARS MARKET, FOR SPRAYS, BY REGION, 2019-2030 (USD BILLION)
TABLE 13 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 14 GLOBAL ARTIFICIAL TEARS MARKET, FOR DRY EYE SYNDROME, BY REGION, 2019-2030 (USD BILLION)
TABLE 15 GLOBAL ARTIFICIAL TEARS MARKET, FOR ALLERGIES AND INFECTIONS, BY REGION, 2019-2030 (USD BILLION)
TABLE 16 GLOBAL ARTIFICIAL TEARS MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)
TABLE 17 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 18 GLOBAL ARTIFICIAL TEARS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019-2030 (USD BILLION)
TABLE 19 GLOBAL ARTIFICIAL TEARS MARKET, FOR DRUG STORES, BY REGION, 2019-2030 (USD BILLION)
TABLE 20 GLOBAL ARTIFICIAL TEARS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019-2030 (USD BILLION)
TABLE 21 GLOBAL ARTIFICIAL TEARS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019-2030 (USD BILLION)
TABLE 22 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, 2019-2030 (USD BILLION)
TABLE 23 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 24 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 25 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 26 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 27 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 28 US: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 29 US: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 30 US: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 31 US: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 32 CANADA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 33 CANADA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 34 CANADA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 35 CANADA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 36 EUROPE: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 37 EUROPE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 38 EUROPE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 39 EUROPE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 40 EUROPE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 41 GERMANY: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 42 GERMANY: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 43 GERMANY: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 44 GERMANY: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 45 UK: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 46 UK: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 47 UK: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 48 UK: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 49 FRANCE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 50 FRANCE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 51 FRANCE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 52 FRANCE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 53 ITALY: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 54 ITALY: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 55 ITALY: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 56 ITALY: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 57 SPAIN: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 58 SPAIN: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 59 SPAIN: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 60 SPAIN: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 61 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 62 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 63 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 64 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 65 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 66 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 67 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 68 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 69 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 70 JAPAN: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 71 JAPAN: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 72 JAPAN: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 73 JAPAN: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 74 CHINA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 75 CHINA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 76 CHINA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 77 CHINA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 78 INDIA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 79 INDIA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 80 INDIA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 81 INDIA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 82 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 83 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 84 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 85 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 86 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 87 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 88 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 89 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 90 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 91 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 92 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 93 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 94 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 95 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 96 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 97 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 98 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 99 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 100 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 101 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 102 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 103 AFRICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 104 AFRICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 105 AFRICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 106 AFRICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 107 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 108 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
TABLE 109 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 110 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
TABLE 111 MAJOR PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET
TABLE 2 MOST ACTIVE PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET
TABLE 3 PRODUCT LAUNCH
TABLE 4 COLLABORATION
TABLE 5 AGREEMENT
TABLE 6 ACQUISITION
TABLE 7 PARTNERSHIP
TABLE 8 JOHNSON AND JOHNSON VISION: PRODUCTS OFFERED
TABLE 9 ALLERGAN PLC: PRODUCTS OFFERED
TABLE 10 ALLERGAN PLC: KEY DEVELOPMENTS
TABLE 11 ALCON PLC: PRODUCTS OFFERED
TABLE 12 ALCON PLC: KEY DEVELOPMENTS
TABLE 13 BAUSCH & LOMB INCORPORATED: PRODUCTS OFFERED
TABLE 14 BAUSCH & LOMB INCORPORATED: KEY DEVELOPMENTS
TABLE 15 SANTEN PHARMACEUTICALS INC.: PRODUCTS OFFERED
TABLE 16 URSAPHARM ARZNEIMITTEL GMBH: PRODUCTS OFFERED
TABLE 17 URSAPHARM ARZNEIMITTEL GMBH: KEY DEVELOPMENTS
TABLE 18 ROHTO PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED
TABLE 19 ROHTO PHARMACEUTICAL CO., LTD.: KEY DEVELOPMENTS
TABLE 20 SIMILASAN CORPORATION: PRODUCTS OFFERED
TABLE 21 OCUSOFT: PRODUCTS OFFERED
TABLE 22 OCUSOFT: KEY DEVELOPMENTS
TABLE 23 NICOX: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL ARTIFICIAL TEARS MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: PROTEIN ENGINEERING MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ARTIFICIAL TEARS MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: ARTIFICIAL TEARS MARKET
FIGURE 9 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE, 2022 & 2030 (USD BILLION)
FIGURE 10 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY TYPE (%), 2022
FIGURE 11 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2022 & 2030 (USD BILLION)
FIGURE 12 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY DELIVERY MODE (%), 2022
FIGURE 13 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION, 2022 & 2030 (USD BILLION)
FIGURE 14 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY APPLICATION (%), 2022
FIGURE 15 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (USD BILLION)
FIGURE 16 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY DISTRIBUTION CHANNEL (%), 2022
FIGURE 17 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, 2022 & 2030 (USD BILLION)
FIGURE 18 GLOBAL ARTIFICIAL TEARS MARKET SHARE (%), BY REGION, 2022
FIGURE 19 NORTH AMERICA: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 20 EUROPE ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 21 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 22 REST OF THE WORLD: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 24 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET
FIGURE 25 GLOBAL ARTIFICIAL TEARS MARKET: COMPETITIVE LANDSCAPE
FIGURE 26 SALES, 2021
FIGURE 27 R&D, 2021
FIGURE 28 JOHNSON AND JOHNSON VISION: SWOT ANALYSIS
FIGURE 29 ALLERGAN PLC: SWOT ANALYSIS
FIGURE 30 ALCON PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 ALCON PLC: SWOT ANALYSIS
FIGURE 32 BAUSCH & LOMB INCORPORATED: SWOT ANALYSIS
FIGURE 33 SANTEN PHARMACEUTICALS INC.: FINANCIAL OVERVIEW
FIGURE 34 SANTEN PHARMACEUTICALS INC.: SWOT ANALYSIS
FIGURE 35 NICOX: FINANCIAL OVERVIEW SNAPSHOT

Product Code: MRFR/HC/10538-CR

Market Overview

The rising pervasiveness of dry eye infection and eye irritation, and the rising inclination for additive free items are driving market development.

The rising interest for additive free artificial tears inferable from the results of additives including eye disturbance, particularly for moderate or serious dry eyes is driving the artificial tears market. Moreover, the rising number of item dispatches by vital participants is expanding item separation and consequently driving market development. For example, In January 2022, Alcon (Switzerland) sent off Systane complete additive free oil eye drops in the European market. Similarly, in October 2019, Allergan, Inc. (Auxiliary of AbbVie, US) sent off the Invigorate Relieva grease eye drop product offering, an extension of the Revive portfolio. The product offering included Revive Relieva PF (additive free) multidose.

Moreover, expanding item dispatches for additive free items is driving the artificial tears market. Besides, propels in bundling plan and conveyance systems for additive free eye drops to forestall tainting are further driving the market for artificial tears market. Hence, expanding inclination for additive free items is driving the market development.

Market Segmentation

Based on type, the Artificial Tears Market is divided into segments such as cellulose, glycerin, propylene glycol, and polyethylene glycol. The market is separated into eye drops, ointments, and sprays based on the mechanism of delivery.

The dry eye condition, allergies, infections, and other conditions are categorized under the application sector of the artificial tears market. Hospital pharmacies, drug stores, retail pharmacies, and internet pharmacies are all part of the distribution system.

Regional Insights

The North America artificial tears market represented the largest market owing to the of the great commonness of dry eye sickness, the presence of market vital participants, and the developing interest for contact focal points in the region Dry eye illness is exceptionally far reaching in the US, influencing a huge level of the populace, especially those beyond 50 years old.

Europe artificial tears market represents the second-largest market owing to the great pervasiveness of ophthalmic issues, expanding utilization of cutting-edge eye drops, and a quickly flooding maturing populace. further, UK artificial tears market was credited to hold the biggest market share, and the France artificial tears market is supposed to quickest developing market in the European region.

The Asia-Pacific artificial tears market is supposed to develop at a fast rate during the review period. This is because of the solid likely persistent populace, rising consciousness of visual illnesses, and expanding medical services consumption in the Asia-Pacific region. Besides, China artificial tears market is supposed to hold the biggest market offer, and India artificial tears market is normal quickest developing market in the Asia-Pacific region.

Major Players

Key Companies in the worldwide Artificial Tears Market are Johnson and Johnson Vision Care (US), Allergan plc (Ireland), Alcon Plc (Switzerland), Bausch & Lomb Incorporated (Canada), Santen, Inc (Japan), URSAPHARM Arzneimittel GmbH (Germany), ROHTO Pharmaceutical CO., LTD (Japan), Similasan Corporation (US), Ocusoft (US), and Nicox (France).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 INCREASING PREVALENCE OF DRY EYE DISEASE AND EYE INFLAMMATION
- 4.2.2 RISING PREFERENCE FOR PRESERVATIVE-FREE PRODUCTS
4.3 RESTRAINTS
- 4.3.1 SIDE-EFFECTS AND ALLERGIC REACTIONS
4.4 OPPORTUNITIES
- 4.4.1 ADVANCEMENT IN DIAGNOSTICS FOR DRY EYE DISEASE

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION AND SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE ARTIFICIAL TEARS MARKET
- 5.3.1 IMPACT ON SUPPLY CHAIN
- 5.3.2 IMPACT ON MANUFACTURERS
5.4 PRICING ANALYSIS

6 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE

6.1 OVERVIEW
6.2 POLYETHYLENE GLYCOL
6.3 PROPYLENE GLYCOL
6.4 CELLULOSE
6.5 GLYCERIN
6.6 OTHERS

7 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE

7.1 OVERVIEW
7.2 EYE DROPS
7.3 OINTMENTS
7.4 SPRAYS

8 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION

8.1 OVERVIEW
8.2 DRY EYE SYNDROME
8.3 ALLERGIES AND INFECTIONS
8.4 OTHERS

9 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW
9.2 HOSPITAL PHARMACIES
9.3 DRUG STORES
9.4 RETAIL PHARMACIES
9.5 ONLINE PHARMACIES

10 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION

10.1 OVERVIEW
10.2 NORTH AMERICA
- 10.2.1 US
- 10.2.2 CANADA
10.3 EUROPE
- 10.3.1 GERMANY
- 10.3.2 UK
- 10.3.3 FRANCE
- 10.3.4 ITALY
- 10.3.5 SPAIN
- 10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC
- 10.4.1 JAPAN
- 10.4.2 CHINA
- 10.4.3 INDIA
- 10.4.4 AUSTRALIA
- 10.4.5 SOUTH KOREA
- 10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
- 10.5.1 MIDDLE EAST
- 10.5.2 AFRICA
- 10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 11.7.1 PRODUCT LAUNCH
- 11.7.2 COLLABORATION
- 11.7.3 AGREEMENT
- 11.7.4 ACQUISITION
- 11.7.5 PARTNERSHIP
11.8 MAJOR PLAYERS FINANCIAL MATRIX
- 11.8.1 SALES (USD BILLION), 2022
- 11.8.2 R&D (USD BILLION), 2022

12 COMPANY PROFILES

12.1 JOHNSON AND JOHNSON VISION CARE
- 12.1.1 COMPANY OVERVIEW
- 12.1.2 FINANCIAL OVERVIEW
- 12.1.3 PRODUCTS OFFERED
- 12.1.4 KEY DEVELOPMENTS
- 12.1.5 SWOT ANALYSIS
- 12.1.6 KEY STRATEGIES
12.2 ALLERGAN PLC
- 12.2.1 COMPANY OVERVIEW
- 12.2.2 FINANCIAL OVERVIEW
- 12.2.3 PRODUCTS OFFERED
- 12.2.4 KEY DEVELOPMENTS
- 12.2.5 SWOT ANALYSIS
- 12.2.6 KEY STRATEGIES
12.3 ALCON PLC
- 12.3.1 COMPANY OVERVIEW
- 12.3.2 FINANCIAL OVERVIEW
- 12.3.3 PRODUCTS OFFERED
- 12.3.4 KEY DEVELOPMENTS
- 12.3.5 SWOT ANALYSIS
- 12.3.6 KEY STRATEGIES
12.4 BAUSCH & LOMB INCORPORATED
- 12.4.1 COMPANY OVERVIEW
- 12.4.2 FINANCIAL OVERVIEW
- 12.4.3 PRODUCTS OFFERED
- 12.4.4 KEY DEVELOPMENTS
- 12.4.5 SWOT ANALYSIS
- 12.4.6 KEY STRATEGIES
12.5 SANTEN, INC.
- 12.5.1 COMPANY OVERVIEW
- 12.5.2 FINANCIAL OVERVIEW
- 12.5.3 PRODUCTS OFFERED
- 12.5.4 KEY DEVELOPMENTS
- 12.5.5 SWOT ANALYSIS
- 12.5.6 KEY STRATEGIES
12.6 URSAPHARM ARZNEIMITTEL GMBH
- 12.6.1 COMPANY OVERVIEW
- 12.6.2 FINANCIAL OVERVIEW
- 12.6.3 PRODUCTS OFFERED
- 12.6.4 KEY DEVELOPMENTS
- 12.6.5 KEY STRATEGIES
12.7 ROHTO PHARMACEUTICAL CO., LTD.
- 12.7.1 COMPANY OVERVIEW
- 12.7.2 FINANCIAL OVERVIEW
- 12.7.3 PRODUCTS OFFERED
- 12.7.4 KEY DEVELOPMENTS
- 12.7.5 KEY STRATEGIES
12.8 SIMILASAN CORPORATION
- 12.8.1 COMPANY OVERVIEWS
- 12.8.2 FINANCIAL OVERVIEW
- 12.8.3 PRODUCTS OFFERED
- 12.8.4 KEY DEVELOPMENTS
- 12.8.5 KEY STRATEGIES
12.9 OCUSOFT
- 12.9.1 COMPANY OVERVIEW
- 12.9.2 FINANCIAL OVERVIEW
- 12.9.3 PRODUCTS OFFERED
- 12.9.4 KEY DEVELOPMENTS
- 12.9.5 KEY STRATEGIES
12.10 NICOX
- 12.10.1 COMPANY OVERVIEW
- 12.10.2 FINANCIAL OVERVIEW
- 12.10.3 PRODUCTS OFFERED
- 12.10.4 KEY DEVELOPMENTS
- 12.10.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES
13.2 RELATED REPORTS

人工涙液の世界市場の予測（～2030年）

Artificial Tears Forecast till 2030

目次

第1章エグゼクティブサマリー

第2章市場のイントロダクション

第3章調査手法

第4章市場力学

第5章市場要因の分析

第6章世界の人工涙市場：タイプ別

第7章世界の人工涙液市場：デリバリー方式別

第8章世界の人工涙液市場：用途別

第9章世界の人工涙液市場：流通チャネル別

第10章世界の人工涙液市場：地域別

第11章競合情勢

第12章企業プロファイル

第13章付録

LIST OF TABLES

LIST OF FIGURES

Market Overview

Market Segmentation

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE

7 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE

8 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION

9 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL

10 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

人工涙液の世界市場の予測（～2030年）

Artificial Tears Forecast till 2030

目次

第1章 エグゼクティブサマリー

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

第5章 市場要因の分析

第6章 世界の人工涙市場：タイプ別

第7章 世界の人工涙液市場：デリバリー方式別

第8章 世界の人工涙液市場：用途別

第9章 世界の人工涙液市場：流通チャネル別

第10章 世界の人工涙液市場：地域別

第11章 競合情勢

第12章 企業プロファイル

第13章 付録

LIST OF TABLES

LIST OF FIGURES

Market Overview

Market Segmentation

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE

7 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE

8 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION

9 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL

10 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

第1章エグゼクティブサマリー

第2章市場のイントロダクション

第3章調査手法

第4章市場力学

第5章市場要因の分析

第6章世界の人工涙市場：タイプ別

第7章世界の人工涙液市場：デリバリー方式別

第8章世界の人工涙液市場：用途別

第9章世界の人工涙液市場：流通チャネル別

第10章世界の人工涙液市場：地域別

第11章競合情勢

第12章企業プロファイル

第13章付録